Carol Gruver
Cardiovascular Disease · Cape Coral, FLNPI 1114916939
Payments from drug & device makers
Across 350 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Novartis$1K
- Pfizer$472
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$409
- Amgen$393
- Boston Scientific$266
- plus $2K from 27 others
What the payments were for
- Food & beverage$5,59497%
- Education$1983%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 96 | $1,285 |
| Novartis | 74 | $1,207 |
| Pfizer | 36 | $472 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 22 | $409 |
| Amgen | 24 | $393 |
| Boston Scientific | 13 | $266 |
| Astellas Pharma US Inc | 5 | $254 |
| Novo Nordisk | 12 | $235 |
| AstraZeneca | 13 | $197 |
| Irhythm Technologies, Inc. | 8 | $142 |
| Merck | 6 | $112 |
| GE HealthCare | 2 | $110 |
| Esperion Therapeutics, Inc. | 5 | $79 |
| Boehringer Ingelheim | 4 | $65 |
| E.r. Squibb & Sons, L.L.C. | 3 | $53 |
| Abbott | 2 | $44 |
| Siemens Medical Solutions USA, Inc. | 2 | $44 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $42 |
| Cardiva Medical, Inc. | 2 | $39 |
| Kowa Pharmaceuticals America, Inc. | 3 | $38 |
| Atricure, Inc. | 1 | $35 |
| Philips North America LLC | 2 | $31 |
| Shockwave Medical, Inc | 1 | $30 |
| Edwards Lifesciences | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 2 | $28 |
| Akcea Therapeutics, Inc. | 2 | $27 |
| Lantheus Medical Imaging, Inc. | 1 | $21 |
| Bayer | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
| Aegerion Pharmaceuticals, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Medtronic | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$141
How this compares
$5,792 in reported general payments places this provider in the 60th percentile of 1,740 cardiovascular disease providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 54 | $50,995 |
| Repatha SureclickEvolocumab | 35 | $25,438 |
| EntrestoSacubitril/Valsartan | 13 | $18,260 |
| VascepaIcosapent Ethyl | 17 | $4,458 |
| Metoprolol Succinate | 97 | $1,217 |
| Ezetimibe | 46 | $751 |
| Rosuvastatin Calcium | 81 | $747 |
| Carvedilol | 33 | $361 |
| ClopidogrelClopidogrel Bisulfate | 37 | $316 |
| Potassium Chloride | 36 | $259 |
| Amlodipine Besylate | 40 | $191 |
| Atorvastatin Calcium | 25 | $145 |
| Losartan Potassium | 16 | $140 |
| Furosemide | 20 | $125 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 12 | $100 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $472 | $50,99554 claims |
| NovartisEntresto | $1,207 | $18,26013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,740 cardiovascular disease providers in Florida.
Other cardiovascular disease in Cape Coral
- Michael KorenGainesville$31M
- Seth BaumBoca Raton$11.1M
- Alexis GutierrezHialeah$8M
- Eric SpivackAventura$7.1M
- William OneillNaples$4.6M
- Rafik AbadierInverness$4.4M
- Alvaro MurciaPembroke Pines$4M
- David HotchkissPort Charlotte$4M
- Ferris GeorgeSt Augustine$3.8M
- Duccio BaldariWellington$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.